Evotec SE has received a $25 million milestone payment from Bristol Myers Squibb, marking further progress in their strategic partnership focused on advancing neuroscience programs. This milestone underlines the ongoing success of the collaboration, which began in December 2016 and
QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and Societal. Murray, who most recently served as CEO of Aprecia Pharmaceutical, brings over 25 years
Avista Healthcare Partners (“Avista”), formerly Avista Capital Partners, has announced the completion of its acquisition of Trillium Health Care Products (“Trillium”). Trillium is a contract development and manufacturing organisation (CDMO) specialising in branded over-the-counter (OTC) products in North America. The
Singota Solutions, a Contract Development and Manufacturing Organization (CDMO) based in Bloomington, Indiana, has announced the expansion of its European services with the opening of a new storage facility in Rovello Porro, Italy. This new facility, certified by the Italian
Chime Biologics has announced plans to significantly scale up its manufacturing operations in China and expand into the Asia-Pacific markets. The contract development and manufacturing organisation (CDMO) will increase its drug substance capacity from 28,000L to approximately 100,000L. This expansion
Andelyn Biosciences, a cell and gene therapy CDMO, has secured a License Agreement with the Broad Institute to integrate MyoAAV plasmids into its AAV Curator™ Platform. Announced on August 7, 2024, this new addition aims to improve the efficiency of
Lonza has enhanced its small molecules facility in Bend, Oregon, by adding clinical bottling and labeling capabilities. Announced on August 6, 2024, the new services build upon the company’s investment in a dedicated early phase clinical manufacturing facility completed in
Samsung Biologics, a global contract development and manufacturing organisation (CDMO), announced its membership in the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This marks the first time a Korean CDMO has joined the PSCI, a group dedicated to
LTS LOHMANN Therapie-Systeme AG (LTS) and Grand River Aseptic Manufacturing (GRAM) have announced a strategic alliance to focus on the sterile fill finish of containers used in LTS’s Sorrel™ wearable injector devices. This partnership offers pharmaceutical companies a comprehensive solution
Biopharma Technology LLC (BTLLC), the United States division of Biopharma Group, has announced a strategic partnership with California-based life sciences company Arete Biosciences. This collaboration aims to establish a dedicated R&D analysis and small batch manufacturing laboratory in the USA
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
